NEW YORK (GenomeWeb) – Roche today announced that Dutch authorities have awarded it a five-year contract to implement the Cobas HPV test to replace traditional Pap smear testing as the first-line, primary screening test in the country's national cervical cancer screening program. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.